Veterinary Medicines

Noroclav 250 mg Tablets for dogs

Authorised
  • Potassium clavulanate
  • Amoxicillin trihydrate
Download as PDF

Product identification

Medicine name:
Noroclav 250 mg Tablets for dogs
Noroclav vet 200 mg/50 mg tabletter til hund
Active substance:
  • Potassium clavulanate
  • Amoxicillin trihydrate
Target species:
  • Dog
  • Cat
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Potassium clavulanate
    59.56
    milligram(s)
    /
    1.00
    Tablet
  • Amoxicillin trihydrate
    229.61
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Withdrawal period by route of administration:
  • Oral use
    • Dog
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01CR02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Norway
Package description:
  • The product is supplied in high-density polyethylene tubs with a polyethylene screw cap lid containing 100 tablets.
  • The product is supplied in high-density polyethylene tubs with a polyethylene screw cap lid containing 250 tablets.
  • The product is presented in packs of 2 blister strips (aluminium-aluminium) each containing 5 tablets per strip.
  • The product is presented in packs of 4 blister strips (aluminium-aluminium) each containing 5 tablets per strip.
  • The product is presented in packs of 10 blister strips (aluminium-aluminium) each containing 5 tablets per strip.
  • The product is presented in packs of 20 strips (aluminium-aluminium) each containing 5 tablets per strip.
  • The product is also presented in packs of 50 blister strips (aluminium-aluminium) each containing 5 tablets per strip.

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Norbrook Laboratories (Ireland) Limited
Marketing authorisation date:
Manufacturing sites for batch release:
  • Norbrook Laboratories Limited
  • Norbrook Manufacturing Limited
Responsible authority:
  • Norwegian Medical Products Agency
Authorisation number:
  • 03-2323
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0546/002
Concerned member states:
  • Austria
  • Belgium
  • Denmark
  • France
  • Luxembourg
  • Netherlands
  • Norway
  • Portugal
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 13/04/2025
Download
Norwegian (PDF)
Published on: 26/01/2022
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Norwegian (PDF)
Published on: 6/03/2023
Download

Combined File of all Documents

English (PDF)
Published on: 13/04/2025
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."